GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bcworldpharm Co Ltd (XKRX:200780) » Definitions » EV-to-EBITDA

Bcworldpharm Co (XKRX:200780) EV-to-EBITDA : 12.98 (As of Dec. 11, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Bcworldpharm Co EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Bcworldpharm Co's enterprise value is ₩113,768 Mil. Bcworldpharm Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 was ₩8,767 Mil. Therefore, Bcworldpharm Co's EV-to-EBITDA for today is 12.98.

The historical rank and industry rank for Bcworldpharm Co's EV-to-EBITDA or its related term are showing as below:

XKRX:200780' s EV-to-EBITDA Range Over the Past 10 Years
Min: -421.44   Med: 21.78   Max: 328.87
Current: 12.97

During the past 11 years, the highest EV-to-EBITDA of Bcworldpharm Co was 328.87. The lowest was -421.44. And the median was 21.78.

XKRX:200780's EV-to-EBITDA is ranked better than
54.18% of 718 companies
in the Drug Manufacturers industry
Industry Median: 14.23 vs XKRX:200780: 12.97

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-12-11), Bcworldpharm Co's stock price is ₩4010.00. Bcworldpharm Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ₩-957.000. Therefore, Bcworldpharm Co's PE Ratio (TTM) for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Bcworldpharm Co EV-to-EBITDA Historical Data

The historical data trend for Bcworldpharm Co's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bcworldpharm Co EV-to-EBITDA Chart

Bcworldpharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 67.87 45.31 49.47 16.42 9.59

Bcworldpharm Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.41 9.59 11.50 13.96 13.73

Competitive Comparison of Bcworldpharm Co's EV-to-EBITDA

For the Drug Manufacturers - General subindustry, Bcworldpharm Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bcworldpharm Co's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bcworldpharm Co's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Bcworldpharm Co's EV-to-EBITDA falls into.



Bcworldpharm Co EV-to-EBITDA Calculation

Bcworldpharm Co's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=113768.221/8767.462
=12.98

Bcworldpharm Co's current Enterprise Value is ₩113,768 Mil.
Bcworldpharm Co's EBITDA for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩8,767 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bcworldpharm Co  (XKRX:200780) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Bcworldpharm Co's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=4010.00/-957.000
=At Loss

Bcworldpharm Co's share price for today is ₩4010.00.
Bcworldpharm Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-957.000.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Bcworldpharm Co EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Bcworldpharm Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Bcworldpharm Co Business Description

Traded in Other Exchanges
N/A
Address
78, Gaepo-ro 22-gil, Gangnam-gu, Seoul, KOR
Bcworldpharm Co Ltd is a pharmaceutical company. The Company's products include Anti-TB, Anti-Diabetic, Analgesics, Narcotics Antidotes and Hemostatics. The products are offered under ALIMA Inj, AROXOL Tab, ASCORBIC Inj and BC CITICOLINE Inj brands.

Bcworldpharm Co Headlines

No Headlines